Cancer affects us all – Towards more personalised cancer care with genetic information – public event on 8.9.2021
Cancer impacts each and every one of us in some way. We are all affected by how cancer is treated and studied.
- Is Finland currently a model country for personalized cancer care, and what does the future hold?
- Does it make a difference to cancer patients in Finland whether or not we have state-of-the-art cancer research in Finland as well?
- What can we anticipate from precision cancer medicine based on increasingly accurate genetic information in the future?
Update your knowledge on the current status, challenges, and future of personalized cancer care and cancer research. Join us as we delve into these current issues with experts and cancer survivors at the University of Helsinki’s Think Corner on Wednesday, September 8, from 17:00 to 18:30.
The event, hosted by Baba Lybeck, will feature discussions with the following individuals:
- Anniina Färkkilä, Associate Professor, Specialist in Gynaecology and Obstetrics, University of Helsinki and HUS
- Tapio Visakorpi, Professor, Dean, Faculty of Medicine and Health Technology, University of Tampere, Finland
- Tuula Helander, Director, Biotechnology and Pharmaceuticals Unit, Ministry of Social Affairs and Health
- Laura Saarelainen, rare cancer survivor
Additionally, there will be video presentations from:
- Jussi Koivunen, Cancer Specialist, Associate Professor, FICAN North
- Tomi Mäkelä, Professor, iCAN, University of Helsinki and HUS
- Bettina Ryll, Melanoma Patient Network Europe, Founder; EU Cancer Mission, Member of the Steering Committee
- Marikki Laiho, Professor, Johns Hopkins University
The event will be streamed and can be followed on the Think Corner website. A recording of the event will be shared on this page at a later date. Please note that the Think Corner is closed to the public due to the current COVID-19 situation.
You can also contribute to the program by sending questions to the speakers, either before or during the event. The event is free of charge, open to all, and part of the Year of Science 2021.
The event is organized in cooperation with the Association of Cancer Patients in Finland, Helsinki Biobank, the Finnish Cancer Institute Foundation, and iCAN, the flagship of digital personalized cancer research at the University of Helsinki and HUS. The event is supported by the Finnish Cancer Institute Foundation and the Association of Cancer Patients in Finland’s the Model Country of Individualized Cancer Care initiative, which is sponsored by six pharmaceutical companies: AstraZeneca, Bristol-Myers Squibb, MSD, Pfizer, Roche, and Takeda.
We welcome you to join us!